| Literature DB >> 31830947 |
Vesal Khalid1,2,3, Henrik Carl Schønheyder4,5, Poul Torben Nielsen6,7,4, Andreas Kappel6,7,4, Trine Rolighed Thomsen8,9, Ramune Aleksyniene10, Jan Lorenzen9, Sten Rasmussen6,7,4.
Abstract
BACKGROUND: Unrecognized periprosthetic joint infections are a concern in revision surgery for aseptic failure (AF) after total hip (THA) or knee (TKA) arthroplasties. A gold diagnostic standard does not exist. The aim of the current study was to determine the prevalence of unrecognized periprosthetic joint infection (PJI) in a cohort of revision for AF, using an experimental diagnostic algorithm.Entities:
Mesh:
Year: 2019 PMID: 31830947 PMCID: PMC6909479 DOI: 10.1186/s12891-019-2944-y
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Flowchart
Demographics and characteristics of 71 patients undergoing revision surgery for suspected aseptic failure of a hip or knee arthroplasty
| Presumed aseptic failure ( | |
| Age, years (mean, SD) | 70 (12.5) |
| Sex, number (females) | 40 |
| Comorbidities ( | |
| Rheumatic disease | 4 |
| Cardiovascular disease | 14 |
| Diabetes mellitus | 7 |
| Cancer | 6 |
| COPD | 4 |
| Biological immunotherapy | 2 |
| BMI (mean, SD) | 29.9 (5.0) |
| Joint | |
| Hip | 35 |
| Knee | 36 |
| Prosthesis, age ( | |
| ≤ 30 days | 1 |
| 31–365 days | 8 |
| 1–5 years | 21 |
| 6–10 years | 9 |
| 11–15 years | 11 |
| ≥ 15 years | 19 |
| Indication for previous surgery ( | |
| Aseptic failure | 7 |
| Prosthetic joint infection | 1 |
| Symptoms and signs at inclusion ( | |
| Pain | 67 |
| Reduced mobility | 38 |
| Swelling | 4 |
| Redness | 2 |
| Warmth | 2 |
Diabetes mellitus: type 1 and type 2; Cardiovascular disease: Hypertension, ischaemic heart disease, COPD: Chronic Obstructive Pulmonary Disease, Cancer: All types except skin cancer treated within the last 5 years; Biological Immunotherapy
aSurgeon’s elicited symptoms
bPatient with revision on two different occasions is featured with the first
Findings in 72 revisions of hip and knee arthroplasties on indication of aseptic failure. The groups are defined by results obtained with the reference method, i.e. culture of five periprosthetic synovial tissue biopsies from each procedure. Gr. 1: 0 positive, Gr. 2–3 positive. Gr. 3: 3–5 positive
| Group 1 | Group 2 | Group 3 | |
|---|---|---|---|
| No. of revisions (and patients) | 62 (61) | 6 | 4 |
| Arthroplasties (no.) | THA 29; TKA 33 | THA 3; TKA 3 | THA 3; TKA1 |
| Prosthesis age, years (median, interquartile range (0.25–0.75)) | 9.2 (2.7–15.8) | 11.8 (3.1–19.9) | 7.6 (5.5–9.2) |
| Prior antibiotic treatment (no.) | 3 | 0 | 0 |
| CRP (μg/mL, (median, interquartile range (0.25–0.75)) | 7.4 (1.5–8.5)c | 6.5 (1–2.5)c | 28.2 (20.3–39.5)c |
| WBC (range 109/L, (median, interquartile range (0.25–0.75)) | 7.2 (6.1–8.4) | 5.9 (3.9–6.8) | 7.5 (6.4–9.1) |
| Number of positive periprosthetic synovial tissue biopsies (a set comprises 5 biopsies) | 0 | 1–2 | 3–5 |
| Reclassification based on work-up of standard tissue samples | |||
| Aseptic failure | 61 | 4 | 0 |
| Prosthetic joint infection | 0 | 1a | 4a |
| Indeterminable | 1a | 1a | 0 |
| Project diagnostics, culture (Cul) and molecular (Mol), number of cases | |||
| Joint fluid | Cul 2 Mol 1 | Cul 2 Mol 0 | Cul 3 Mol 1 |
| Sonication fluid | Cul 2 Mol 0 | Cul 1 Mol 1 | Cul 3 Mol 3 |
| Bone biopsy | Cul 0 Mol 2 | ─ | Cul 1 Mol 0 |
| Swab from prosthetic element | Cul 1 Mol 3 | ─ | Cul 2 Mol 1 |
| Follow-up period, days (median & range) | 396 (3b-1097) | 367 (47–1131) | 363 (96–1051) |
| Indication for revision during follow-up | |||
| Aseptic failure | 4 | 0 | 0 |
| Prosthetic joint infection | 1 | 0 | 0 |
aCase 1–6 and 11 in Appendix 3
bPatient died from cardiac arrest during admittance
cMissing values: Group 1: 11; Group 2: 1; Group 3: 1
Indication and information regarding exchange of components during revision surgery of THA or TKA. Ortopaedic surgeons notify routinely the two Danish National Arthroplasty Registries for hip or knee arthroplasties. If information was missing the medical record was an alternative source
| THA | |
| Aseptic failure of | |
| Femur and acetabulum component with osteolysis | 4 |
| Femur component with osteolysis | 9 |
| Femur component without osteolysis | 4 |
| Acetabulum component with osteolysis | 9 |
| Acetabulum component without osteolysis | 5 |
| Supracondylar femoral fracture | 2 |
| Other | 2 |
| Components exchanged | |
| Total replacement | 4 |
| Single components | |
| Acetabulum component | 13 |
| Acetabulum liner | 16 |
| Caput | 23 |
| Femur component | 12 |
| Soft tissue revision without exchange of prosthesis | 1 |
| TKA | |
| Aseptic failure of | |
| Tibia component | 17 |
| Tibia and femoral component | 3 |
| Femur component | 1 |
| Tibia polyethylene | 5 |
| Instability | 5 |
| Other | 5 |
| Components exchanged | |
| Total replacement | 10 |
| Single components | |
| Tibia component | 23 |
| Femur component | 15 |
| Patella component | 2 |
| Soft tissue revision without exchange of prosthesis | 1 |
| Periprosthetic tissue | Joint fluid | Sonication | Bone | Swab | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Case nr./Re-classification from AF | Culture | PCR | Culture | PCR | Culture | PCR | Culture | PCR | Culture | PCR |
1 PJI | Neg | Neg | Neg | Neg | ||||||
2 PJI | Ne | Neg | Neg | Neg | Neg | Neg | ||||
3 PJI | 3/5 | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg |
4 PJI | Neg | ___ | Neg | |||||||
| Periprosthetic tissue | Joint fluid | Sonication | Bone | Swab | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Case nr./Re-classification from AF | Culture | PCR | Culture | PCR | Culture | PCR | Culture | PCR | Culture | PCR |
5 PJI | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | ||
6 PJI-indeter. | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | ||
7 AF | ___ | Neg | Neg | Neg | Neg | ___ | Neg | ___ | ||
8 AF | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | |
9 AF | Neg | Neg | Neg | Neg | Neg | Neg | Neg | ___ | ___ | |
10 AF | CoNS (2/5) | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg |
| Periprosthetic tissue | Joint fluid | Sonication | Bone | Swab | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Case nr./Re-classification from AF | Culture | PCR | Culture | PCR | Culture | PCR | Culture | PCR | Culture | PCR |
11 PJI-indeter. | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | ||
12 AF | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | |
13 AF | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | |
14 AF | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | |
15 AF | Neg | Neg | ___ | Neg | Neg | Neg | ___ | ___ | Neg | |
16 AF | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | ||
17 AF | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | |
18 AF | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | |
19 AF | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | |
≥3 positive cultures with the same microorganism(s) 2 positive cultures with the same microorganism(s) Absence of above criteria |